Outcomes of the HORNBILL study: A phase I/IIa investigating Sema3A modulator in participants with DMI

media

posted on 2024-11-19, 10:33 authored by Quan Dong Nguyen, Chirag Jhaveri, Maged Habib, Khaled Nassar, Bartlomiej Krawczyk, Michel Wagner, Martin Gliem, Sobha Sivaprasad

The above is a video summary of a clinical trial for diabetic retinopathy with diabetic macular ischemia. The content is not peer-reviewed. Unless otherwise specified, the content on this website has undergone a medical, legal, and regulatory (MLR) review and approval process by Boehringer Ingelheim.